Jasper Therapeutics, Inc. · NASDAQ:JSPR
Jasper Therapeutics, Inc. shareholders
As of Jun 30, 2026, 44 institutions reported holding Jasper Therapeutics, Inc., 36.1% of its shares. Largest: Velan Capital Investment Management LP, Acorn Capital Advisors, LLC and Kingdon Capital Management, L.L.C. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Jasper Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Velan Capital Investment Management LP | 2.67M | 8.0% | no change | Aug 14, 2026 |
| Acorn Capital Advisors, LLC | 1.44M | 4.3% | +26,667 | Aug 14, 2026 |
| Kingdon Capital Management, L.L.C. | 1.35M | 4.1% | no change | Aug 14, 2026 |
| Vanguard | 1.32M | 4.0% | −576 | Aug 13, 2026 |
| Rock Springs Capital Management LP | 1.1M | 3.3% | no change | Aug 14, 2026 |
| Carlyle Group Inc. | 1.07M | 3.2% | no change | Aug 7, 2026 |
| Gsa Capital Partners LLP | 535K | 1.6% | +516K | Aug 6, 2026 |
| Millennium | 487K | 1.5% | −1.13M | Aug 14, 2026 |
| Lion Point Capital, LP | 465K | 1.4% | no change | Aug 14, 2026 |
| Geode Capital | 264K | 0.79% | −53,869 | Aug 12, 2026 |